4.3 Article

Reactive oxygen species in follicular fluid may serve as biochemical markers to determine ovarian aging and follicular metabolic age

Journal

GYNECOLOGICAL ENDOCRINOLOGY
Volume 30, Issue 10, Pages 705-707

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.3109/09513590.2014.924100

Keywords

Ageing; follicle; H2O2; ovary; reactive oxygen species

Ask authors/readers for more resources

Introduction: The aim of this study was to evaluate the role of oxidative stress in the process of ovarian aging. Methods: Follicular fluid (FF) from two randomly selected sibling follicles was collected from women undergoing in-vitro fertilization and tested for hydrogen peroxide (H2O2) levels. Results: Group A consists of seven women with whom each of the two sibling separate follicle yielded an oocyte that was later discordantly developed to a low-and top-quality embryo. Group B consists of 13 patients in whom one of the sibling follicle yielded an oocyte while the other did not (empty follicle). High-quality embryos were derived from follicles with lower H2O2 levels compared to follicles from which poor-quality embryos developed (1.004 units +/- 0.260 versus 1.145 units +/- 0.236, p<0.02). H2O2 levels were significantly higher (0.951 units +/- 0.233 versus 0.623 units +/- 0.309, p<0.001) in sibling follicles containing oocyte compared to empty follicles. Conclusion: During the process of ovarian ageing, there might be a gradual increase in H2O2 level in the follicle. Finally, when the follicle ages and becomes empty of oocyte H2O2 levels drops significantly. Therefore, H2O2 levels in FF may serve as a possible marker to determine ovarian aging and follicular metabolic age.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Endocrinology & Metabolism

FMR6 may play a role in the pathogenesis of fragile X-associated premature ovarian insufficiency

Shai E. Elizur, Olga Dratviman-Storobinsky, Sanaz Derech-Haim, Oshrit Lebovitz, Jehoshua Dor, Raoul Orvieto, Yoram Cohen

GYNECOLOGICAL ENDOCRINOLOGY (2016)

Article Acoustics

Prenatal Brain Imaging in Isolated vs. Complicated Club Foot: A Cohort Study

I. Gat, O. Bar Yosef, C. Hoffmann, O. Lebovitz, D. Shashar, Y. Gilboa, I. Yagel, R. Achiron, E. Katorza

ULTRASCHALL IN DER MEDIZIN (2016)

Article Genetics & Heredity

Outcome of gestational surrogacy according to IVF protocol

Ronit Machtinger, Nir-Ram Duvdevani, Oshrit Lebovitz, Jehoshua Dor, Ariel Hourvitz, Raoul Orvieto

JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2017)

Article Obstetrics & Gynecology

The clinical value of maternal and fetal Doppler parameters in low-risk postdates pregnancies - a prospective study

Oshrit Lebovitz, Eran Barzilay, Shali Mazaki-Tovi, Itai Gat, Reuven Achiron, Yinon Gilboa

JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2018)

Article Obstetrics & Gynecology

Pelvic inflammatory disease in women with endometriosis is more severe than in those without

Shai E. Elizur, Oshrit Lebovitz, Adi Y. Weintraub, Vered H. Eisenberg, Daniel S. Seidman, Mordechai Goldenberg, David Soriano

AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY (2014)

Meeting Abstract Obstetrics & Gynecology

OVARIAN PERFORMANCE, IVF RESULTS, PREGNANCIES AND LIVE BIRTHS INDICATE; FERTILITY PRESERVATION USING OVARIAN TISSUE HARVESTING AND TRANSPLANTATION OF THAWED OVARIAN STRIPS IS EFFECTIVE.

D. Meirow, H. Raanani, M. Brenghausen, O. Lebovitz, R. Orvieto, J. Dor

FERTILITY AND STERILITY (2014)

Meeting Abstract Obstetrics & Gynecology

REPEATING ANNUAL FERTILITY ASSESSMENT: IS IT REALLY NECESSARY?

O. Lebovitz, R. Orvieto, K. James, J. C. Petrozza

FERTILITY AND STERILITY (2018)

Article Obstetrics & Gynecology

Safety of low-dose prostaglandin E2 induction in grandmultiparous women with previous cesarean delivery

Jigal Haas, Eran Barzilay, Benny Chayen, Oshrit Lebovitz, Yoav Yinon, Shali Mazaki-Tovi, Linda Harel

JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2014)

Article Multidisciplinary Sciences

Elevated Levels of FMR1 mRNA in Granulosa Cells Are Associated with Low Ovarian Reserve in FMR1 Premutation Carriers

Shai E. Elizur, Oshrit Lebovitz, Sanaz Derech-Haim, Olga Dratviman-Storobinsky, Baruch Feldman, Jehoshua Dor, Raoul Orvieto, Yoram Cohen

PLOS ONE (2014)

Article Obstetrics & Gynecology

The expected cumulative incidence of live birth for patients starting IVF treatment at age 41 years or older

Oshrit Lebovitz, Jigal Haas, Kaitlyn E. James, Daniel S. Seidman, Raoul Orvieto, Ariel Hourvitz

REPRODUCTIVE BIOMEDICINE ONLINE (2018)

Article Reproductive Biology

Does daily co administration of gonadotropins and letrozole during the ovarian stimulation improve IVF outcome for poor and sub optimal responders?

Moran Shapira, Raoul Orvieto, Oshrit Lebovitz, Ravit Nahum, Adva Aizer, Aliza Segev-Zahav, Jigal Haas

JOURNAL OF OVARIAN RESEARCH (2020)

Article Reproductive Biology

Degenerated oocyte in the cohort adversely affects IVF outcome

Yuval Atzmon, Mediea Michaeli, Diana Poltov, Nechami Rotfarb, Oshrit Lebovitz, Nardin Aslih, Einat Shalom-Paz

JOURNAL OF OVARIAN RESEARCH (2020)

Article Genetics & Heredity

The role of ICSI vs. conventional IVF for patients with advanced maternal age-a randomized controlled trial

Jigal Haas, Tal Elkan Miller, Ravit Nahum, Adva Aizer, Michal Kirshenbaum, Eran Zilberberg, Oshrit Lebovitz, Raoul Orvieto

Summary: The study aimed to evaluate the role of intracytoplasmic sperm injection (ICSI) in non-male factor infertile patients aged >= 39, but found that ICSI does not improve reproductive outcomes for advanced-age patients undergoing conventional insemination for non-male factor infertility.

JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2021)

Meeting Abstract Obstetrics & Gynecology

The impact of advanced maternal age on early and late morphokinetic parameters

O. Lebovitz, Y. Atzmon, N. Aslih, M. Michaeli, D. Paltov, E. Shalom-Paz

HUMAN REPRODUCTION (2020)

Meeting Abstract Obstetrics & Gynecology

FMR6 (a long non coding RNA) may play a role in the pathogenesis of fragile X associated premature ovarian insufficiency (FXPOI).

S. E. Elizur, O. Dratviman-Storobinsky, S. Derech-Haim, O. Lebovitz, J. Dor, R. Orvieto, Y. Cohen

HUMAN REPRODUCTION (2015)

No Data Available